SEHA - 2023 SPEAKERS
Prof Eric Allémann
Université de Genève
Prof Eric Allémann
Université de Genève
Eric Allémann was born in 1963. He studied pharmacy at the University of Geneva. From 1990 to 1993, he worked on his thesis in the field of parenteral polymeric drug delivery systems with extended release properties. He obtained his Ph.D. in 1993. He went then to the Faculty of Medicine of the University of Sherbrooke (Quebec) for a post-doc. In 1995, he became research associate and lecturer at the University of Geneva. In 1997, the Swiss Confederation for the renewal of academic positions appointed him. He obtained in October 1999 a position of “maître d'enseignement et de recherche”. Since October 2001, he joined the Geneva research center of the pharmaceutical company Bracco Group, as senior research scientist. He was involved in therapeutic and diagnostic nanomedicines. In 2004, he was appointed Manager and was heading the Department of Novel Agents Research at Bracco Research Geneva. In 2009 he became full professor of Pharmaceutical technology at the Geneva-Lausanne School of Pharmacy (EPGL), located at the University of Geneva. Since July 2018, he was elected President of the School of pharmaceutical sciences. Eric Allémann's research interests are focused on the delivery of active substances by means of supramolecular constructs, nano- and microparticles for the controlled release and drug targeting as well as for contrast agents for various medical imaging techniques.
He is (co)-inventor for 15 international patents and has authored and co-authored more than 100 research and review articles.
Additionally to his academic duties, Eric is co-founder of KYLYS a start-up company developing biopolymers
Prof Juan M. Irache
University of Navarra
Prof Juan M. Irache
University of Navarra
Juan M. IRACHE is Professor of Pharmaceutical Technology at the University of Navarra. He was a postdoctoral fellow at the Department of Galenics in the University of Paris South (1992-1993) and Associate Professor (Maître de Conférences Universitaire) at the University of Rouen in France (1993-1996). His research is focused on the design and evaluation of nanocarriers (e.g., polymer nanoparticles, SNEDDS, protein nanodevices) for (i) the delivery of drugs, actives and biomacromolecules through biological barriers, and (ii) the development of new mucosal adjuvants for vaccination and immunotherapy.
Dr Krisztina Ludasi
University of Szeged
Dr Krisztina Ludasi
University of Szeged
Personal Data
Name: Dr. Krisztina Ludasi
Email: ludasi.krisztina@szte.hu
Studies:
PhD degree, University of Szeged, 2021
Quality Assurance Pharmacist, University of Szeged, 2020
Masters degree in Pharmacy, University of Albert Szent-Györgyi, 1996
Work experice:
Assistant lecturer, University of Szeged, Institute of Pharmaceutical Technology and Regulatory Affairs, since 2019
PhD student, University of Szeged, Institute of Pharmaceutical Technology and Regulatory Affairs, 2016-2019
QA pharmacist, ExtractumPharma Zrt, 2015
Key account manager, sales representative at ExtractumPharma Zrt., Lilly Hungária Kft., Sanofi-Aventis Zrt., Aventis, Hoechst Marion Roussel Pharmaceutical companies, 1997-2015
Pharmaceutical sales representative, Pharmafontana Pharmaceutical Rt., 1996-1997
Field of Research:
Development of anti-counterfeiting drug identification technologies using laser technology
Film coating of solid pharmaceutical dosage forms.
Dr Stéphane Veesler
CINaM-CNRS, Aix-Marseille University
Dr Stéphane Veesler
CINaM-CNRS, Aix-Marseille University
Stéphane Veesler is an academic researcher from Aix-Marseille University. The author has contributed to research in topic(s): Crystallization & Nucleation. The author has an hindex of 34, co-authored 119 publication(s) receiving 3251 citation(s). Previous affiliations of Stéphane Veesler include Centre national de la recherche scientifique & University of California, Santa Barbara.
Pr Ines Esma Achouri
Université de Sherbrooke
Pr Ines Esma Achouri
Université de Sherbrooke
Titulaire de la Chaire de Recherche du Canada en intensification des procédés pour catalyseurs avancés et énergie durable
Diplômes
- Baccalauréat Génie des Procédés, spécialité procédés Pharmaceutiques, Université Constantine 3 et Université Laarbi Ben M’hidi, Algérie (2008)
- Master Ingénierie Biomédicale et Pharmaceutique, Université Claude Bernard Lyon 1, France (2009)
- Doctorat en Génie Chimique, Université de Sherbrooke (2015)
- Chercheure postdoctorale, École Polytechnique de Montréal (2018)
Domaines d'expertises et de recherche
Intensification des procédés chimiques et pharmaceutiques; Efficacité énergétique; Catalyseurs hétérogènes, Procédé assisté par plasma froid; Conversion catalytique.
Activités de recherche
- Développement de matériaux efficaces pour la production d’énergie
- Développement et optimisation de procédés à haute efficacité énergétique
- Développement de techniques d’opération en continu
Pr Abdelkader Hadj Sadok
University of Blida
Pr Abdelkader Hadj Sadok
University of Blida
Abdelkader Hadj Sadok was born in Khémis Meliana in 1964. He earned his bachelor's degree in physics from Houari Boumediene University of Science and Technology (USTHB) in 1987. He began working as a teacher/researcher at the University of Blida in 1988. He obtained a master's degree in fluid mechanics at the USTHB in 1993. He then worked on his thesis named " Etude rhéologique et physicochimique des systèmes à structure complexe à base de caséinate de sodium" and received his Ph.D. from the University of Blida in 2009. In June 2014, he was granted the ability to conduct research. He has been a Professor since July 2019. He has more than 30 scientific research articles, with over 400 citations.
Pr. Hadj Sadok has also served as a consultant at CRD Saidal (1994-2010), Biopharm since 2007, and Venus, Wanylab, SARL Alger Chimie, and laboratoires Groupe Santé since 2017, 2018, 2020, and 2021, respectively.